Advanced breast cancer
diagnostic device launched. Early, painless and comprehensive detection of
onset cancer is now made possible with the new Biofield Diagnostic System
(BDS). The BDS is a breast cancer diagnostic device that uses advanced sensor
technology. It was recently launched in the Philippines by Mackay Eastern
Medical Group, this device aims to providing quick and confirmatory cancer
diagnosis within 20 minutes.
Photo shows Louis W.C. Chow, MBBS,MS,
FRCS, FCSHK, FHKAM, FACS, Medical
Director of the Comprehensive Centre for Breast Diseases at the UNIMED Medical
Institute in Hong Kong. He is one of
the esteemed guest speakers during the launch discussing the many advantages of
the BDS, which also include a painless alternative for women who would want a
convenient and fast diagnosis of breast lesions.
About Mackay Eastern
Medical Group
MacKay
Eastern Medical Group (MEMG) is one of the pioneering companies in the Philippines in
the field of non invasive and advanced medical technologies. The company has
the sole rights of distributing the BIOFIELD DIAGNOSTIC SYSTEM for breast
cancer detection in the Philippines
and the ASEAN Region.MacKay Eastern is
also the sole distributor of the FM 200 BioMask, an anti-infective facemask
that can kill pathogens within minutes of contact while retaining high levels
of breathability and comfort.
MEMG
is working to create public breast cancer awareness and is committed to
providing quality service and products for both medical professionals and
civilians.